nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.119	0.147	CbGbCtD
Nefazodone—CYP3A7—Rifampicin—leprosy	0.119	0.147	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0982	0.121	CbGbCtD
Nefazodone—CYP3A7—Dapsone—leprosy	0.0982	0.121	CbGbCtD
Nefazodone—CYP3A5—Thalidomide—leprosy	0.0921	0.114	CbGbCtD
Nefazodone—CYP3A5—Rifampicin—leprosy	0.0892	0.11	CbGbCtD
Nefazodone—CYP3A5—Dapsone—leprosy	0.0736	0.0908	CbGbCtD
Nefazodone—ABCB1—Rifampicin—leprosy	0.0581	0.0716	CbGbCtD
Nefazodone—CYP3A4—Rifampicin—leprosy	0.0348	0.0429	CbGbCtD
Nefazodone—CYP3A4—Dapsone—leprosy	0.0287	0.0354	CbGbCtD
Nefazodone—Hangover—Thalidomide—leprosy	0.00564	0.033	CcSEcCtD
Nefazodone—Suicide attempt—Dapsone—leprosy	0.00457	0.0267	CcSEcCtD
Nefazodone—Hernia—Thalidomide—leprosy	0.00283	0.0166	CcSEcCtD
Nefazodone—Neck stiffness—Thalidomide—leprosy	0.00279	0.0163	CcSEcCtD
Nefazodone—Grand mal convulsion—Thalidomide—leprosy	0.00279	0.0163	CcSEcCtD
Nefazodone—Sinus bradycardia—Thalidomide—leprosy	0.00271	0.0158	CcSEcCtD
Nefazodone—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.0026	0.0152	CcSEcCtD
Nefazodone—Nuchal rigidity—Thalidomide—leprosy	0.00256	0.015	CcSEcCtD
Nefazodone—Hostility—Thalidomide—leprosy	0.0024	0.014	CcSEcCtD
Nefazodone—Vesiculobullous rash—Thalidomide—leprosy	0.00237	0.0139	CcSEcCtD
Nefazodone—Suicide attempt—Thalidomide—leprosy	0.00234	0.0137	CcSEcCtD
Nefazodone—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00229	0.0134	CcSEcCtD
Nefazodone—Enlargement abdomen—Thalidomide—leprosy	0.00221	0.0129	CcSEcCtD
Nefazodone—HTR2A—trigeminal nerve—leprosy	0.00213	0.117	CbGeAlD
Nefazodone—Oral candidiasis—Thalidomide—leprosy	0.00209	0.0122	CcSEcCtD
Nefazodone—Tooth disorder—Thalidomide—leprosy	0.00205	0.012	CcSEcCtD
Nefazodone—Galactorrhoea—Thalidomide—leprosy	0.00205	0.012	CcSEcCtD
Nefazodone—Neuralgia—Thalidomide—leprosy	0.00191	0.0112	CcSEcCtD
Nefazodone—Hyperaesthesia—Thalidomide—leprosy	0.00169	0.0099	CcSEcCtD
Nefazodone—Rash pustular—Thalidomide—leprosy	0.00167	0.00974	CcSEcCtD
Nefazodone—Influenza—Dapsone—leprosy	0.00163	0.00952	CcSEcCtD
Nefazodone—SLC6A3—nerve—leprosy	0.0016	0.0881	CbGeAlD
Nefazodone—HTR2A—cranial nerve—leprosy	0.00152	0.0834	CbGeAlD
Nefazodone—Accidental injury—Thalidomide—leprosy	0.0015	0.00878	CcSEcCtD
Nefazodone—Photosensitivity reaction—Dapsone—leprosy	0.00149	0.00869	CcSEcCtD
Nefazodone—Musculoskeletal stiffness—Thalidomide—leprosy	0.00148	0.00866	CcSEcCtD
Nefazodone—Cellulitis—Thalidomide—leprosy	0.00146	0.00854	CcSEcCtD
Nefazodone—Thinking abnormal—Thalidomide—leprosy	0.00145	0.00848	CcSEcCtD
Nefazodone—Oliguria—Thalidomide—leprosy	0.00144	0.00843	CcSEcCtD
Nefazodone—Hypercholesterolaemia—Thalidomide—leprosy	0.0014	0.00821	CcSEcCtD
Nefazodone—Atrioventricular block—Thalidomide—leprosy	0.00137	0.00801	CcSEcCtD
Nefazodone—Sinusitis—Dapsone—leprosy	0.00136	0.00796	CcSEcCtD
Nefazodone—Gait disturbance—Thalidomide—leprosy	0.00136	0.00796	CcSEcCtD
Nefazodone—Coordination abnormal—Thalidomide—leprosy	0.00135	0.00791	CcSEcCtD
Nefazodone—Neck pain—Thalidomide—leprosy	0.00134	0.00786	CcSEcCtD
Nefazodone—Eructation—Thalidomide—leprosy	0.00131	0.00763	CcSEcCtD
Nefazodone—Pharyngitis—Dapsone—leprosy	0.00129	0.00756	CcSEcCtD
Nefazodone—SLC6A2—nerve—leprosy	0.00129	0.0711	CbGeAlD
Nefazodone—HTR2A—hindlimb—leprosy	0.00128	0.0703	CbGeAlD
Nefazodone—Colitis—Thalidomide—leprosy	0.00128	0.00746	CcSEcCtD
Nefazodone—Candida infection—Thalidomide—leprosy	0.00127	0.00742	CcSEcCtD
Nefazodone—Dry eye—Thalidomide—leprosy	0.00123	0.00717	CcSEcCtD
Nefazodone—Tinnitus—Dapsone—leprosy	0.00122	0.0071	CcSEcCtD
Nefazodone—Oesophagitis—Thalidomide—leprosy	0.00121	0.0071	CcSEcCtD
Nefazodone—Rash maculo-papular—Thalidomide—leprosy	0.00121	0.00706	CcSEcCtD
Nefazodone—Lightheadedness—Thalidomide—leprosy	0.00119	0.00695	CcSEcCtD
Nefazodone—Gynaecomastia—Thalidomide—leprosy	0.00119	0.00695	CcSEcCtD
Nefazodone—ADRA2A—peripheral nervous system—leprosy	0.00117	0.0645	CbGeAlD
Nefazodone—Hypertonia—Thalidomide—leprosy	0.00116	0.00681	CcSEcCtD
Nefazodone—Hyperkinesia—Thalidomide—leprosy	0.00116	0.00677	CcSEcCtD
Nefazodone—Mental disability—Thalidomide—leprosy	0.00115	0.00674	CcSEcCtD
Nefazodone—Euphoric mood—Thalidomide—leprosy	0.00114	0.00667	CcSEcCtD
Nefazodone—Lymphadenopathy—Thalidomide—leprosy	0.00113	0.00661	CcSEcCtD
Nefazodone—HTR2A—appendage—leprosy	0.0011	0.0603	CbGeAlD
Nefazodone—Gastroenteritis—Thalidomide—leprosy	0.00109	0.00636	CcSEcCtD
Nefazodone—Deafness—Thalidomide—leprosy	0.00108	0.0063	CcSEcCtD
Nefazodone—Eczema—Thalidomide—leprosy	0.00107	0.00627	CcSEcCtD
Nefazodone—Vision blurred—Dapsone—leprosy	0.00107	0.00625	CcSEcCtD
Nefazodone—Eye pain—Thalidomide—leprosy	0.00107	0.00625	CcSEcCtD
Nefazodone—Cardiac failure congestive—Thalidomide—leprosy	0.00106	0.00622	CcSEcCtD
Nefazodone—Injury—Thalidomide—leprosy	0.00105	0.00613	CcSEcCtD
Nefazodone—Libido decreased—Thalidomide—leprosy	0.00104	0.00608	CcSEcCtD
Nefazodone—Increased appetite—Thalidomide—leprosy	0.00103	0.006	CcSEcCtD
Nefazodone—Vertigo—Dapsone—leprosy	0.00102	0.00596	CcSEcCtD
Nefazodone—Visual disturbance—Thalidomide—leprosy	0.00102	0.00595	CcSEcCtD
Nefazodone—Dermatitis bullous—Thalidomide—leprosy	0.00101	0.0059	CcSEcCtD
Nefazodone—HTR2A—peripheral nervous system—leprosy	0.000996	0.0548	CbGeAlD
Nefazodone—Arthritis—Thalidomide—leprosy	0.000992	0.0058	CcSEcCtD
Nefazodone—Cough—Dapsone—leprosy	0.00099	0.00579	CcSEcCtD
Nefazodone—Hypoglycaemia—Thalidomide—leprosy	0.000988	0.00578	CcSEcCtD
Nefazodone—Cerebrovascular accident—Thalidomide—leprosy	0.000984	0.00575	CcSEcCtD
Nefazodone—Hyponatraemia—Thalidomide—leprosy	0.000968	0.00566	CcSEcCtD
Nefazodone—Diplopia—Thalidomide—leprosy	0.000965	0.00564	CcSEcCtD
Nefazodone—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000965	0.00564	CcSEcCtD
Nefazodone—Osteoarthritis—Thalidomide—leprosy	0.000965	0.00564	CcSEcCtD
Nefazodone—Disturbance in sexual arousal—Thalidomide—leprosy	0.000957	0.00559	CcSEcCtD
Nefazodone—Migraine—Thalidomide—leprosy	0.000949	0.00555	CcSEcCtD
Nefazodone—Affect lability—Thalidomide—leprosy	0.000949	0.00555	CcSEcCtD
Nefazodone—Face oedema—Thalidomide—leprosy	0.000931	0.00544	CcSEcCtD
Nefazodone—Mood swings—Thalidomide—leprosy	0.000914	0.00534	CcSEcCtD
Nefazodone—Ataxia—Thalidomide—leprosy	0.000907	0.0053	CcSEcCtD
Nefazodone—Tachycardia—Dapsone—leprosy	0.000904	0.00528	CcSEcCtD
Nefazodone—Dehydration—Thalidomide—leprosy	0.000897	0.00524	CcSEcCtD
Nefazodone—Liver function test abnormal—Thalidomide—leprosy	0.00089	0.00521	CcSEcCtD
Nefazodone—Dry skin—Thalidomide—leprosy	0.000884	0.00517	CcSEcCtD
Nefazodone—Orthostatic hypotension—Thalidomide—leprosy	0.000881	0.00515	CcSEcCtD
Nefazodone—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000869	0.00508	CcSEcCtD
Nefazodone—Cramp muscle—Thalidomide—leprosy	0.000869	0.00508	CcSEcCtD
Nefazodone—Alanine aminotransferase increased—Thalidomide—leprosy	0.000851	0.00497	CcSEcCtD
Nefazodone—Abdominal distension—Thalidomide—leprosy	0.000839	0.00491	CcSEcCtD
Nefazodone—Insomnia—Dapsone—leprosy	0.000838	0.0049	CcSEcCtD
Nefazodone—Influenza—Thalidomide—leprosy	0.000834	0.00487	CcSEcCtD
Nefazodone—Dysphagia—Thalidomide—leprosy	0.000834	0.00487	CcSEcCtD
Nefazodone—Angina pectoris—Thalidomide—leprosy	0.000812	0.00475	CcSEcCtD
Nefazodone—Bronchitis—Thalidomide—leprosy	0.000802	0.00469	CcSEcCtD
Nefazodone—HTR2A—nerve—leprosy	0.000777	0.0427	CbGeAlD
Nefazodone—Pollakiuria—Thalidomide—leprosy	0.00077	0.0045	CcSEcCtD
Nefazodone—Erectile dysfunction—Thalidomide—leprosy	0.000768	0.00449	CcSEcCtD
Nefazodone—Photosensitivity reaction—Thalidomide—leprosy	0.000761	0.00445	CcSEcCtD
Nefazodone—Weight increased—Thalidomide—leprosy	0.000759	0.00444	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dapsone—leprosy	0.000757	0.00443	CcSEcCtD
Nefazodone—Weight decreased—Thalidomide—leprosy	0.000754	0.00441	CcSEcCtD
Nefazodone—Pneumonia—Thalidomide—leprosy	0.000748	0.00437	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000737	0.00431	CcSEcCtD
Nefazodone—Body temperature increased—Dapsone—leprosy	0.000732	0.00428	CcSEcCtD
Nefazodone—Abdominal pain—Dapsone—leprosy	0.000732	0.00428	CcSEcCtD
Nefazodone—Stomatitis—Thalidomide—leprosy	0.000725	0.00424	CcSEcCtD
Nefazodone—Conjunctivitis—Thalidomide—leprosy	0.000722	0.00422	CcSEcCtD
Nefazodone—Sweating—Thalidomide—leprosy	0.000713	0.00417	CcSEcCtD
Nefazodone—Haematuria—Thalidomide—leprosy	0.000709	0.00414	CcSEcCtD
Nefazodone—Epistaxis—Thalidomide—leprosy	0.000701	0.0041	CcSEcCtD
Nefazodone—Sinusitis—Thalidomide—leprosy	0.000697	0.00408	CcSEcCtD
Nefazodone—Bradycardia—Thalidomide—leprosy	0.000679	0.00397	CcSEcCtD
Nefazodone—Rhinitis—Thalidomide—leprosy	0.000669	0.00391	CcSEcCtD
Nefazodone—Hepatitis—Thalidomide—leprosy	0.000667	0.0039	CcSEcCtD
Nefazodone—Hypoaesthesia—Thalidomide—leprosy	0.000664	0.00388	CcSEcCtD
Nefazodone—Pharyngitis—Thalidomide—leprosy	0.000662	0.00387	CcSEcCtD
Nefazodone—Oedema peripheral—Thalidomide—leprosy	0.000657	0.00384	CcSEcCtD
Nefazodone—Visual impairment—Thalidomide—leprosy	0.000643	0.00376	CcSEcCtD
Nefazodone—Erythema multiforme—Thalidomide—leprosy	0.000631	0.00369	CcSEcCtD
Nefazodone—Tinnitus—Thalidomide—leprosy	0.000622	0.00364	CcSEcCtD
Nefazodone—HTR2A—blood vessel—leprosy	0.00061	0.0336	CbGeAlD
Nefazodone—Chills—Thalidomide—leprosy	0.000599	0.0035	CcSEcCtD
Nefazodone—Alopecia—Thalidomide—leprosy	0.00059	0.00345	CcSEcCtD
Nefazodone—Vomiting—Dapsone—leprosy	0.000589	0.00344	CcSEcCtD
Nefazodone—Headache—Dapsone—leprosy	0.00058	0.00339	CcSEcCtD
Nefazodone—Flatulence—Thalidomide—leprosy	0.000572	0.00335	CcSEcCtD
Nefazodone—Dysgeusia—Thalidomide—leprosy	0.000569	0.00333	CcSEcCtD
Nefazodone—Back pain—Thalidomide—leprosy	0.000562	0.00328	CcSEcCtD
Nefazodone—Muscle spasms—Thalidomide—leprosy	0.000558	0.00326	CcSEcCtD
Nefazodone—Nausea—Dapsone—leprosy	0.00055	0.00322	CcSEcCtD
Nefazodone—Vision blurred—Thalidomide—leprosy	0.000547	0.0032	CcSEcCtD
Nefazodone—Tremor—Thalidomide—leprosy	0.000544	0.00318	CcSEcCtD
Nefazodone—Ill-defined disorder—Thalidomide—leprosy	0.000539	0.00315	CcSEcCtD
Nefazodone—Anaemia—Thalidomide—leprosy	0.000537	0.00314	CcSEcCtD
Nefazodone—Agitation—Thalidomide—leprosy	0.000534	0.00312	CcSEcCtD
Nefazodone—Angioedema—Thalidomide—leprosy	0.000531	0.0031	CcSEcCtD
Nefazodone—Malaise—Thalidomide—leprosy	0.000524	0.00306	CcSEcCtD
Nefazodone—Vertigo—Thalidomide—leprosy	0.000522	0.00305	CcSEcCtD
Nefazodone—Syncope—Thalidomide—leprosy	0.000521	0.00305	CcSEcCtD
Nefazodone—Leukopenia—Thalidomide—leprosy	0.00052	0.00304	CcSEcCtD
Nefazodone—Palpitations—Thalidomide—leprosy	0.000513	0.003	CcSEcCtD
Nefazodone—Loss of consciousness—Thalidomide—leprosy	0.000511	0.00298	CcSEcCtD
Nefazodone—Cough—Thalidomide—leprosy	0.000507	0.00296	CcSEcCtD
Nefazodone—Convulsion—Thalidomide—leprosy	0.000503	0.00294	CcSEcCtD
Nefazodone—Hypertension—Thalidomide—leprosy	0.000501	0.00293	CcSEcCtD
Nefazodone—Myalgia—Thalidomide—leprosy	0.000495	0.00289	CcSEcCtD
Nefazodone—Arthralgia—Thalidomide—leprosy	0.000495	0.00289	CcSEcCtD
Nefazodone—Chest pain—Thalidomide—leprosy	0.000495	0.00289	CcSEcCtD
Nefazodone—Anxiety—Thalidomide—leprosy	0.000493	0.00288	CcSEcCtD
Nefazodone—Discomfort—Thalidomide—leprosy	0.000489	0.00286	CcSEcCtD
Nefazodone—Dry mouth—Thalidomide—leprosy	0.000484	0.00283	CcSEcCtD
Nefazodone—ADRA1B—nervous system—leprosy	0.000481	0.0265	CbGeAlD
Nefazodone—Confusional state—Thalidomide—leprosy	0.000478	0.00279	CcSEcCtD
Nefazodone—Oedema—Thalidomide—leprosy	0.000474	0.00277	CcSEcCtD
Nefazodone—Infection—Thalidomide—leprosy	0.000471	0.00275	CcSEcCtD
Nefazodone—Shock—Thalidomide—leprosy	0.000466	0.00273	CcSEcCtD
Nefazodone—Thrombocytopenia—Thalidomide—leprosy	0.000464	0.00271	CcSEcCtD
Nefazodone—Tachycardia—Thalidomide—leprosy	0.000463	0.0027	CcSEcCtD
Nefazodone—Hyperhidrosis—Thalidomide—leprosy	0.000458	0.00268	CcSEcCtD
Nefazodone—Anorexia—Thalidomide—leprosy	0.000452	0.00264	CcSEcCtD
Nefazodone—Hypotension—Thalidomide—leprosy	0.000443	0.00259	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000432	0.00252	CcSEcCtD
Nefazodone—Insomnia—Thalidomide—leprosy	0.000429	0.00251	CcSEcCtD
Nefazodone—Paraesthesia—Thalidomide—leprosy	0.000426	0.00249	CcSEcCtD
Nefazodone—Dyspnoea—Thalidomide—leprosy	0.000423	0.00247	CcSEcCtD
Nefazodone—Somnolence—Thalidomide—leprosy	0.000421	0.00246	CcSEcCtD
Nefazodone—Dyspepsia—Thalidomide—leprosy	0.000417	0.00244	CcSEcCtD
Nefazodone—Decreased appetite—Thalidomide—leprosy	0.000412	0.00241	CcSEcCtD
Nefazodone—Pain—Thalidomide—leprosy	0.000405	0.00237	CcSEcCtD
Nefazodone—Constipation—Thalidomide—leprosy	0.000405	0.00237	CcSEcCtD
Nefazodone—ABCB1—blood vessel—leprosy	0.0004	0.022	CbGeAlD
Nefazodone—Feeling abnormal—Thalidomide—leprosy	0.000391	0.00228	CcSEcCtD
Nefazodone—Gastrointestinal pain—Thalidomide—leprosy	0.000388	0.00227	CcSEcCtD
Nefazodone—Urticaria—Thalidomide—leprosy	0.000377	0.0022	CcSEcCtD
Nefazodone—Body temperature increased—Thalidomide—leprosy	0.000375	0.00219	CcSEcCtD
Nefazodone—Abdominal pain—Thalidomide—leprosy	0.000375	0.00219	CcSEcCtD
Nefazodone—SLC6A3—testis—leprosy	0.000367	0.0202	CbGeAlD
Nefazodone—SLC6A3—nervous system—leprosy	0.00036	0.0198	CbGeAlD
Nefazodone—Hypersensitivity—Thalidomide—leprosy	0.000349	0.00204	CcSEcCtD
Nefazodone—HTR2C—nervous system—leprosy	0.000348	0.0192	CbGeAlD
Nefazodone—Asthenia—Thalidomide—leprosy	0.00034	0.00199	CcSEcCtD
Nefazodone—Pruritus—Thalidomide—leprosy	0.000335	0.00196	CcSEcCtD
Nefazodone—SLC6A4—nervous system—leprosy	0.00033	0.0182	CbGeAlD
Nefazodone—HTR2A—eye—leprosy	0.000325	0.0179	CbGeAlD
Nefazodone—Diarrhoea—Thalidomide—leprosy	0.000324	0.0019	CcSEcCtD
Nefazodone—Dizziness—Thalidomide—leprosy	0.000313	0.00183	CcSEcCtD
Nefazodone—Vomiting—Thalidomide—leprosy	0.000301	0.00176	CcSEcCtD
Nefazodone—Rash—Thalidomide—leprosy	0.000299	0.00175	CcSEcCtD
Nefazodone—Dermatitis—Thalidomide—leprosy	0.000299	0.00175	CcSEcCtD
Nefazodone—Headache—Thalidomide—leprosy	0.000297	0.00174	CcSEcCtD
Nefazodone—SLC6A2—testis—leprosy	0.000296	0.0163	CbGeAlD
Nefazodone—HTR1A—nervous system—leprosy	0.000293	0.0161	CbGeAlD
Nefazodone—SLC6A2—nervous system—leprosy	0.000291	0.016	CbGeAlD
Nefazodone—Nausea—Thalidomide—leprosy	0.000282	0.00165	CcSEcCtD
Nefazodone—ADRA1A—nervous system—leprosy	0.00027	0.0149	CbGeAlD
Nefazodone—ADRA2A—tendon—leprosy	0.000253	0.0139	CbGeAlD
Nefazodone—HTR2A—tendon—leprosy	0.000215	0.0118	CbGeAlD
Nefazodone—ADRA2A—testis—leprosy	0.000209	0.0115	CbGeAlD
Nefazodone—ADRA2A—nervous system—leprosy	0.000205	0.0113	CbGeAlD
Nefazodone—HTR2A—testis—leprosy	0.000178	0.00979	CbGeAlD
Nefazodone—HTR2A—nervous system—leprosy	0.000175	0.00961	CbGeAlD
Nefazodone—CYP2D6—testis—leprosy	0.000162	0.00892	CbGeAlD
Nefazodone—CYP3A4—nervous system—leprosy	0.000162	0.0089	CbGeAlD
Nefazodone—CYP2D6—nervous system—leprosy	0.000159	0.00876	CbGeAlD
Nefazodone—ABCB1—testis—leprosy	0.000117	0.00642	CbGeAlD
Nefazodone—ABCB1—nervous system—leprosy	0.000114	0.0063	CbGeAlD
